Search Results - Anca Milea
- Showing 1 - 3 results of 3
-
1
Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma by Anca Milea, Sophia George, Donco Matevski, Haiyan Jiang, Mary Madunic, Hal K. Berman, Mona L. Gauthier, Brenda L. Gallie, Patricia A. Shaw
Published 2013Artigo -
2
A distinct innate lymphoid cell population regulates tumor-associated T cells by Sarah Q. Crome, Linh T. Nguyen, Sandra López‐Vergès, S.Y. Cindy Yang, Bernard Martin, Jennifer Yam, Dylan J. Johnson, Jessica Nie, Michael Pniak, Pei Hua Yen, Anca Milea, Ramlogan Sowamber, Sarah Rachel Katz, Marcus Q. Bernardini, Blaise Clarke, Patricia A. Shaw, Philipp A. Lang, Hal K. Berman, Trevor J. Pugh, Lewis L. Lanier, Pamela S. Ohashi
Published 2017Artigo -
3
Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies by Stephen M. Ansell, Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas, Mark D. Minden, Diego Villa, Mary‐Elizabeth M. Percival, Anjali S. Advani, James M. Foran, Steven M. Horwitz, Matthew Mei, Jasmine Zain, Kerry J. Savage, Christiane Querfeld, Oleg E. Akilov, Lisa D. Johnson, Tina Catalano, Penka S. Petrova, Robert A. Uger, Eric L. Sievers, Anca Milea, Kathleen Roberge, Yaping Shou, Owen A. O’Connor
Published 2021Artigo
Search Tools:
Related Subjects
Medicine
Biology
Cancer
Cancer research
Gene
Genetics
Internal medicine
Adverse effect
Astrobiology
Cell biology
Cell cycle
Chemotherapy
Chills
Clinical endpoint
Clinical trial
Context (archaeology)
Cyclin D1
Cytotoxic T cell
Debulking
Environmental health
Gastroenterology
Immune system
Immunology
Immunotherapy
In vitro
Innate immune system
Innate lymphoid cell
Interleukin 21
Lymphoma
Meta-analysis